Cardiff and Vale University Health Board is the local health board of NHS Wales for Cardiff and Vale of Glamorgan, in the south-east of Wales. Formed on 1 October 2009 through the amalgamation of three NHS organisations in the Cardiff and Vale of Glamorgan area.

During the past decade, Cardiff and Vale University Health Board conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 6 clinical trials were completed, i.e. on average, 16.2% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 4 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiff and Vale University Health Board" #1 sponsor was "Cardiff and Vale University Health Board" with 6 trials, followed by "University College, London" with 3 trials sponsored, "Guy's and St Thomas' NHS Foundation Trust" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Medtronic Vascular" with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiff and Vale University Health Board" #1 collaborator was "Cardiff University" with 5 trials as a collaborator, "University College, London" with 4 trials as a collaborator, "Cardiff and Vale University Health Board" with 3 trials as a collaborator, "King's College London" with 3 trials as a collaborator and "National Institute for Health Research, United Kingdom" with 3 trials as a collaborator. Other collaborators include 80 different institutions and companies that were collaborators in the rest 75 trials.

According to Clinical.Site data, the most researched conditions in "Cardiff and Vale University Health Board" are "Covid19" (3 trials), "Cancer" (2 trials), "Cardiovascular Diseases" (2 trials), "Critical Illness" (2 trials) and "Hemophilia A" (2 trials). Many other conditions were trialed in "Cardiff and Vale University Health Board" in a lesser frequency.

Most popular intervention types in "Cardiff and Vale University Health Board" are "Drug" (14 trials), "Procedure" (8 trials), "Other" (6 trials), "Device" (5 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Emicizumab" (2 trials), "Sham Procedure" (2 trials), "Symplicity Spyral™ multi-electrode renal denervation system" (2 trials) and "Adjuvant therapies" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiff and Vale University Health Board" are 40 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Cardiff and Vale University Health Board". undefined are not yet recruiting, 14 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Cardiff and Vale University Health Board, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiff and Vale University Health Board, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 13 trials that are defined as “Not Applicable".